Show
Sort by
-
Microbiome and metabolome dynamics during radiotherapy for prostate cancer
-
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial
-
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
-
- Journal Article
- A1
- open access
Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature
-
A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy
-
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
-
- Journal Article
- A1
- open access
Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma
-
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
-
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures